Covadonga Paneda
Department Of R&D
Madrid, MD, Spain
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 09, 2024
Synthetic nanocarriers for the delivery of polynucleotides to the eye.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: December 30, 2016
Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease.
Journal: Investigative ophthalmology & visual science
Published: November 29, 2016
In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 13, 2013
Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 13, 2013
Differential expression and localization of transient receptor potential vanilloid 1 in rabbit and human eyes.
Journal: Histology and histopathology
Published: May 28, 2013
Silencing human genetic diseases with oligonucleotide-based therapies.
Journal: Human genetics
Published: December 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026